ENG Gene Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين ENG لتوسع الشعيرات النزفي الوراثي من النوع 1 (HHT1) بتقنية التسلسل الجيني من الجيل التالي NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

ملخص تنفيذي: اختبار جيني لتشخيص توسع الشعيرات النزفي الوراثي النوع الأول (HHT1) بدقة فائقة وخدمة منزلية معتمدة.

🔬 Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS processing.
🏡 Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM–11 PM).
🩺 Clinical Guidance: Complimentary telephonic post-test clinical interpretation by a DHA-licensed genetic counselor.
💳 Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.

Overview: Precision Diagnosis for Hereditary Hemorrhagic Telangiectasia Type 1

This advanced Genetic Test analyzes the entire ENG gene to identify pathogenic variants causing HHT1 (Osler-Weber-Rendu syndrome), characterized by abnormal blood vessel formation and multi‑organ arteriovenous malformations. يوفر هذا التحليل الجيني تأكيدًا دقيقًا للطفرات المسببة للمرض ويتيح التدخل المبكر وتخطيط الأسرة.

Feature	Our ENG NGS Test	Closest Alternative (Sanger Sequencing)
Method	Targeted NGS (full gene, all exons & splice sites)	Single‑variant or limited exon analysis
Variant Detection	SNVs, indels, and copy number variants (CNV) with 99.9% sensitivity	Only known hotspots; misses novel/rare variants
Turnaround Time	3–4 weeks	3–4 weeks
Clinical Utility	Comprehensive diagnosis, family cascade screening	Confirmatory only for known familial mutation

Physician Insight & Safety Protocol

“As a clinician, I understand that visible telangiectasias or unexplained epistaxis can be distressing. This genetic test provides clarity, but a negative result does not entirely exclude HHT if clinical criteria are met; it should always be correlated with a detailed vascular assessment and family history.” — Dr. PRABHAKAR REDDY, DHA License 61713011

⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing clinical surveillance.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion: Acute febrile illness, active systemic infection, or recent blood transfusion (within 2 weeks) may affect sample suitability.
Exclusion: Sample volume <1 mL whole blood or inadequate DNA yield on FTA card.
ER Red Flag: Sudden severe nosebleed not controlled by pressure, acute chest pain or breathlessness (possible pulmonary AVM rupture), sudden severe headache with neurological deficit (cerebral AVM bleed) – seek emergency care immediately. This test is not for acute crisis management.

Patient FAQ & Clinical Guidance

Q: What does the ENG gene test detect?

A: This test identifies pathogenic DNA variants in the ENG gene causing Hereditary Hemorrhagic Telangiectasia type 1. It comprehensively screens for single nucleotide changes, small insertions/deletions, and copy number alterations, enabling early detection of vascular malformations and family screening. يحدد هذا الاختبار الطفرات الجينية الممرضة في جين ENG المسبّبة لتوسع الشعيرات النزفي الوراثي من النوع الأول، مما يتيح الكشف المبكر عن التشوهات الوعائية وفحص أفراد الأسرة.

Q: How is the sample collected?

A: A simple blood draw (or FTA card spot) is performed by a certified phlebotomist, with home collection available. Our VIP mobile service ensures cold‑chain transport from your doorstep to the laboratory. No fasting or special preparation is required. تُجمع العينة بسحب دم بسيط (أو بقعة على بطاقة FTA) عبر ممرض معتمد، مع إمكانية السحب المنزلي المبرد للحفاظ على الجودة.

Q: What does a positive result mean?

A: A positive result confirms a genetic diagnosis of HHT1, prompting surveillance for AV malformations and family screening. You will be referred to a specialist for a tailored management plan, including imaging studies (MRI, CT) if indicated, even before symptoms appear. النتيجة الإيجابية تؤكد تشخيص HHT1 وتستدعي المراقبة الدورية للتشوهات الوعائية وفحص الأقارب، مع خطة علاجية وقائية.

This is performed under UAE Medical Laboratory License No. 9834453, adhering to Federal Decree‑Law No. 41 of 2024 (Article 87: Quality Assurance) and the UAE Personal Data Protection Law (PDPL). Testing of minors requires consent in compliance with the UAE Child Protection Law (CDS Law 2026). ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).

دعم ثنائي اللغة متاح